Author | Steve Waxman, MD


Management of Asymptomatic Rising PSA After Prostatectomy or Radiation Therapy

April 01, 1997

BySteve Waxman, MD|Amy K. Stevens, MD|Richard A. Walsh, MD|E. David Crawford, MD

Controversy exists over the optimal management of patients with an asymptomatic rising prostate-specific antigen (PSA) following definitive therapy for clinically localized prostate adenocarcinoma.